These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19054324)

  • 1. The activation peptide of thrombin-activatable fibrinolysis inhibitor: a role in activity and stability of the enzyme?
    Marx PF; Plug T; Havik SR; Mörgelin M; Meijers JC
    J Thromb Haemost; 2009 Mar; 7(3):445-52. PubMed ID: 19054324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of a stable thrombin-activatable fibrinolysis inhibitor deletion mutant exerting full carboxypeptidase activity without activation.
    Zhou X; Declerck PJ
    J Thromb Haemost; 2015 Jun; 13(6):1084-9. PubMed ID: 25773535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmin-mediated activation and inactivation of thrombin-activatable fibrinolysis inhibitor.
    Marx PF; Dawson PE; Bouma BN; Meijers JC
    Biochemistry; 2002 May; 41(21):6688-96. PubMed ID: 12022872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of zinc ions in activation and inactivation of thrombin-activatable fibrinolysis inhibitor.
    Marx PF; Bouma BN; Meijers JC
    Biochemistry; 2002 Jan; 41(4):1211-6. PubMed ID: 11802720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective modulation of thrombin-activatable fibrinolysis inhibitor (TAFI) activation by thrombin or the thrombin-thrombomodulin complex using TAFI-derived peptides.
    Plug T; Marquart JA; Marx PF; Meijers JC
    J Thromb Haemost; 2015 Nov; 13(11):2093-101. PubMed ID: 26341360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidation of the molecular mechanisms of two nanobodies that inhibit thrombin-activatable fibrinolysis inhibitor activation and activated thrombin-activatable fibrinolysis inhibitor activity.
    Zhou X; Weeks SD; Ameloot P; Callewaert N; Strelkov SV; Declerck PJ
    J Thromb Haemost; 2016 Aug; 14(8):1629-38. PubMed ID: 27279497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased zymogen activity of thrombin-activatable fibrinolysis inhibitor prolongs clot lysis.
    Mishra N; Buelens K; Theyskens S; Compernolle G; Gils A; Declerck PJ
    J Thromb Haemost; 2012 Jun; 10(6):1091-9. PubMed ID: 22498006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of rat thrombin-activatable fibrinolysis inhibitor (TAFI)--a comparative study assessing the biological equivalence of rat, murine and human TAFI.
    Hillmayer K; Macovei A; Pauwels D; Compernolle G; Declerck PJ; Gils A
    J Thromb Haemost; 2006 Nov; 4(11):2470-7. PubMed ID: 17002650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of isoleucine residues 182 and 183 in thrombin-activatable fibrinolysis inhibitor.
    Marx PF; Havik SR; Bouma BN; Meijers JC
    J Thromb Haemost; 2005 Jun; 3(6):1293-300. PubMed ID: 15946220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin-activatable fibrinolysis inhibitor antigen and TAFI activity in patients with APC resistance caused by factor V Leiden mutation.
    Antovic JP; Blombäck M
    Thromb Res; 2002 Apr; 106(1):59-62. PubMed ID: 12165290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into thrombin activatable fibrinolysis inhibitor function and regulation.
    Foley JH; Kim PY; Mutch NJ; Gils A
    J Thromb Haemost; 2013 Jun; 11 Suppl 1():306-15. PubMed ID: 23809134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles of selected arginine and lysine residues of TAFI (Pro-CPU) in its activation to TAFIa by the thrombin-thrombomodulin complex.
    Wu C; Kim PY; Manuel R; Seto M; Whitlow M; Nagashima M; Morser J; Gils A; Declerck P; Nesheim ME
    J Biol Chem; 2009 Mar; 284(11):7059-67. PubMed ID: 19074424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical characterization of bovine plasma thrombin-activatable fibrinolysis inhibitor (TAFI).
    Valnickova Z; Thaysen-Andersen M; Højrup P; Christensen T; Sanggaard KW; Kristensen T; Enghild JJ
    BMC Biochem; 2009 May; 10():13. PubMed ID: 19416536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin activatable fibrinolysis inhibitor activation and bleeding in haemophilia A.
    Foley JH; Nesheim ME; Rivard GE; Brummel-Ziedins KE
    Haemophilia; 2012 May; 18(3):e316-22. PubMed ID: 21933309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme.
    Schneider M; Boffa M; Stewart R; Rahman M; Koschinsky M; Nesheim M
    J Biol Chem; 2002 Jan; 277(2):1021-30. PubMed ID: 11684677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there thrombin-activatable fibrinolysis inhibitor in saliva?
    Chopra S; Friman E; Krüger CW; Antovic JP; Naimi-Akbar A
    Br J Oral Maxillofac Surg; 2020 Nov; 58(9):e33-e37. PubMed ID: 32507642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of a stable activated thrombin activable fibrinolysis inhibitor variant.
    Ceresa E; Van de Borne K; Peeters M; Lijnen HR; Declerck PJ; Gils A
    J Biol Chem; 2006 Jun; 281(23):15878-83. PubMed ID: 16595693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of stable TAFIa variants: importance of alpha-helix 9 and beta-sheet 11 for TAFIa (in)stability.
    Ceresa E; De Maeyer M; Jonckheer A; Peeters M; Engelborghs Y; Declerck PJ; Gils A
    J Thromb Haemost; 2007 Oct; 5(10):2105-12. PubMed ID: 17666015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin-activatable fibrinolysis inhibitor in human abdominal aortic aneurysm disease.
    Bridge KI; Bollen L; Zhong J; Hesketh M; Macrae FL; Johnson A; Philippou H; Scott DJ; Gils A; Ariёns RAS
    J Thromb Haemost; 2017 Nov; 15(11):2218-2225. PubMed ID: 28834317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma and recombinant thrombin-activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/thrombomodulin-dependent activation, thermal stability, and enzymatic properties.
    Boffa MB; Wang W; Bajzar L; Nesheim ME
    J Biol Chem; 1998 Jan; 273(4):2127-35. PubMed ID: 9442053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.